“신답오피Δ YEOTOP4.COM Δ 여탑 ◈또다시◈신답오피✬신답풀싸롱✮신답출장ⅶ신답립카페✖신답휴게텔ª신답OP”的搜索结果，显示 211-220 项，共有 8909 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to compare the effect of adding nivolumab to the usual chemotherapy (cisplatin or carboplatin with gemcitabine) versus the ...

2. 神经科- 临床试验- 妙佑医疗国际

   Jacksonville, Fla. The purpose of this study is to evaluate the safety, pharmacokinetics and biodistribution of an imaging agent, 18F-OP-801 (18F Hydroxyl ...

3. 神经科- 临床试验- 妙佑医疗国际

   Jacksonville, Fla. The purpose of this study is to evaluate the safety, pharmacokinetics and biodistribution of an imaging agent, 18F-OP-801 (18F Hydroxyl ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The objective of this pilot stdy is to plan, develop and establish the acceptance and usability of a Point of Prostate Cancer Diagnosis (PPCD) iCCaRE ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Jacksonville, Fla. The purpose of this study is to compare the effect of adding nivolumab to the usual chemotherapy (cisplatin or carboplatin with gemcitabine) ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer cells, ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer cells, ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate a new treatment using a potent Poly polymerase (PARP) inhibitor known as Niraparib. Niraparib will be combined with ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... 7% of patients develop CHF (median follow-up 8.5 years). Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... 7% of patients develop CHF (median follow-up 8.5 years). Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus ...